FDA Adverse Event Malfunction Summary report: N

BD PLASTIPAK¿ SYRINGES

MDR report key: 13996221 · Received April 4, 2022

Report

Report Number
3003152976-2022-00133
Event Type
Malfunction
Date Received
April 4, 2022
Date of Event
February 14, 2022
Report Date
May 5, 2022
Manufacturer
BECTON DICKINSON, S.A.
Product Code
FMF
PMA / PMN Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

MEDICAL DEVICE EXPIRATION DATE: UNKNOWN. DEVICE MANUFACTURE DATE: UNKNOWN. LOT NUMBER WAS NOT REPORTED; HOWEVER, A POTENTIAL LOT NUMBER WAS PROVIDED. THE INFORMATION FOR THAT NUMBER IS AS FOLLOWS: MEDICAL DEVICE LOT #: 2111091. MEDICAL DEVICE EXPIRATION DATE: 31OCT2026. DEVICE MANUFACTURE DATE: 10NOV2021. A DEVICE EVALUATION IS ANTICIPATED BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Additional Manufacturer Narrative · 0

H.6. INVESTIGATION: NO PHOTOS OR PHYSICAL SAMPLES THAT DISPLAY THE REPORTED CONDITION WERE AVAILABLE FOR INVESTIGATION. A DEVICE HISTORY REVIEW WAS PERFORMED FOR THE SUSPECTED LOT 2111091, NO DEVIATIONS OR NON-CONFORMANCES WERE IDENTIFIED DURING THE MANUFACTURING PROCESS THAT COULD HAVE CONTRIBUTED TO THIS ISSUE. TEN RETAINED SAMPLES OF LOT 2111091 WERE USED FOR ADDITIONAL EVALUATION. THE PRODUCT WAS VISUALLY INSPECTED, NO DEFECTS OR DAMAGE WAS NOTED, THE STOPPERS WERE PROPERLY ASSEMBLED, AND NO LEAKS WERE IDENTIFIED DURING TESTING. BASED ON THE AVAILABLE INFORMATION WE ARE NOT ABLE TO DETERMINE A ROOT CAUSE AT THIS TIME.

Description of Event or Problem · 0

IT WAS REPORTED WHILE USING BD PLASTIPAK¿ SYRINGES LEAKAGE OCCURRED BEHIND THE STOPPER. THERE WAS NO REPORT OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: LEAKAGE OF ANTICANCER AGENT THAT PASSES UNDER THE PLUNGER OF THE SYRINGE DURING THE PREPARATION OF ANTICANCER CHEMOTHERAPY.

Description of Event or Problem · 0

IT WAS REPORTED WHILE USING BD PLASTIPAK¿ SYRINGES LEAKAGE OCCURRED BEHIND THE STOPPER. THERE WAS NO REPORT OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: LEAKAGE OF ANTICANCER AGENT THAT PASSES UNDER THE PLUNGER OF THE SYRINGE DURING THE PREPARATION OF ANTICANCER CHEMOTHERAPY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
81974 BD PLASTIPAK¿ SYRINGES PISTON SYRINGE FMF BECTON DICKINSON, S.A. UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 Unknown